PODD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
801.7M
+5.3%
761.7M
-2.8%
783.8M
+11.0%
706.3M
+8.8%
649.1M
Cost of Revenue
239.1M
+2.8%
232.7M
+8.1%
215.2M
+9.7%
196.2M
-0.4%
196.9M
Gross Profit
562.6M
+6.4%
529.0M
-7.0%
568.6M
+11.5%
510.1M
+12.8%
452.2M
Operating Expenses
432.9M
+6.4%
406.9M
-3.6%
422.3M
+7.6%
392.4M
+18.5%
331.1M
R&D
88.1M
-1.8%
89.7M
-1.3%
90.9M
+17.7%
77.2M
+5.2%
73.4M
SG&A
344.8M
+8.7%
317.2M
-4.3%
331.4M
+5.1%
315.2M
+22.3%
257.7M
Operating Income
129.7M
+6.2%
122.1M
-16.5%
146.3M
+24.3%
117.7M
-2.8%
121.1M
EBITDA
156.4M
+5.5%
148.3M
-13.1%
170.7M
+22.2%
139.7M
-2.6%
143.4M
Net Income
95.0M
+4.3%
91.1M
-10.3%
101.6M
+16.0%
87.6M
+289.3%
22.5M
EPS (Basic)
$1.37
+5.4%
$1.30
-9.7%
$1.44
+16.1%
$1.24
+287.5%
$0.32
EPS (Diluted)
$1.37
+5.4%
$1.30
-7.8%
$1.41
+13.7%
$1.24
+287.5%
$0.32
Shares (Diluted)
69.4M
-1.1%
70.2M
-2.7%
72.1M
+2.1%
70.7M
+0.0%
70.7M
Insulet (PODD) โ€” Financials